Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 216

1.

Potential effect of anti-inflammatory treatment on reducing the cardiovascular risk in rheumatoid arthritis.

Chighizola C, Schioppo T, Ingegnoli F, Meroni PL.

Curr Vasc Pharmacol. 2012 Sep;10(5):639-46. Review.

PMID:
22272912
2.

Cardiovascular risk in rheumatoid arthritis.

Nurmohamed MT.

Autoimmun Rev. 2009 Jul;8(8):663-7. doi: 10.1016/j.autrev.2009.02.015. Epub 2009 Feb 12. Review.

PMID:
19393192
3.

Potential effect of anti-tumour necrosis factor-alpha treatment on reducing the cardiovascular risk related to rheumatoid arthritis.

Cugno M, Ingegnoli F, Gualtierotti R, Fantini F.

Curr Vasc Pharmacol. 2010 Mar;8(2):285-92. Review.

PMID:
19485909
5.

[Chronic inflammation increases the risk of cardiovascular disease in patients with rheumatoid arthritis].

Troelsen LN, Jacobsen S.

Ugeskr Laeger. 2006 Sep 25;168(39):3304-8. Review. Danish.

PMID:
17032593
6.

Cardiovascular risk in rheumatoid arthritis: how to lower the risk?

van Breukelen-van der Stoep DF, Klop B, van Zeben D, Hazes JM, Castro Cabezas M.

Atherosclerosis. 2013 Nov;231(1):163-72. doi: 10.1016/j.atherosclerosis.2013.09.006. Epub 2013 Sep 20. Review.

PMID:
24125429
7.

Reducing the cardiovascular disease burden in rheumatoid arthritis.

Van Doornum S, Jennings GL, Wicks IP.

Med J Aust. 2006 Mar 20;184(6):287-90. Review.

PMID:
16548834
8.

Cardiovascular risk in rheumatoid arthritis: effects of anti-TNF drugs.

Avouac J, Allanore Y.

Expert Opin Pharmacother. 2008 May;9(7):1121-8. doi: 10.1517/14656566.9.7.1121. Review.

PMID:
18422470
9.

Therapy Insight: managing cardiovascular risk in patients with rheumatoid arthritis.

Giles JT, Post W, Blumenthal RS, Bathon JM.

Nat Clin Pract Rheumatol. 2006 Jun;2(6):320-9. Review.

PMID:
16932711
10.
11.

Rheumatoid arthritis: cardiovascular manifestations, pathogenesis, and therapy.

Mellana WM, Aronow WS, Palaniswamy C, Khera S.

Curr Pharm Des. 2012;18(11):1450-6. Review.

PMID:
22364129
12.

[Rheumatoid arthritis--a risk factor of ischemic heart disease].

Hollan I, Mikkelsen K, Førre Ø.

Tidsskr Nor Laegeforen. 2005 Dec 1;125(23):3259-62. Review. Norwegian.

13.

[Rheumatoid arthritis, inflammation, and atherosclerosis].

Hürlimann D, Enseleit F, Ruschitzka F.

Herz. 2004 Dec;29(8):760-8. Review. German.

PMID:
15599672
14.

Cardiovascular risk factors in inflammatory arthritis.

Mirjafari H, Al-Husain A, Bruce IN.

Curr Opin Lipidol. 2011 Aug;22(4):296-301. doi: 10.1097/MOL.0b013e3283488c50. Review.

PMID:
21670670
15.

Cardiovascular morbidity and mortality in patients with rheumatoid arthritis: vascular alterations and possible clinical implications.

Pieringer H, Pichler M.

QJM. 2011 Jan;104(1):13-26. doi: 10.1093/qjmed/hcq203. Epub 2010 Nov 10. Review.

PMID:
21068083
16.

Targeting inflammation as a therapeutic strategy in accelerated atherosclerosis in rheumatoid arthritis.

Full LE, Monaco C.

Cardiovasc Ther. 2011 Aug;29(4):231-42. doi: 10.1111/j.1755-5922.2010.00159.x. Epub 2010 Jun 14. Review.

PMID:
20553292
17.

Atherosclerosis and inflammation: insights from rheumatoid arthritis.

Chung CP, Avalos I, Raggi P, Stein CM.

Clin Rheumatol. 2007 Aug;26(8):1228-33. Epub 2007 Feb 2. Review.

PMID:
17273810
18.

Impact of traditional therapies and biologics on cardiovascular diseases in rheumatoid arthritis.

Boyer JF, Cantagrel A, Constantin A.

Curr Vasc Pharmacol. 2008 Jul;6(3):218-27. Review.

PMID:
18673161
19.

[Cardiovascular risk in systemic inflammatory diseases].

Marsico F, Parente A, Paolillo S, Casaretti L, Lo Iudice F, Pirozzi E, Conte S, Iardino E, Gambardella F, Della Ratta GL, Cirillo A, Vitagliano A, Filardi PP.

G Ital Cardiol (Rome). 2013 Jul-Aug;14(7-8):517-25. doi: 10.1714/1308.14460. Review. Italian.

PMID:
23877549
20.

Cardiovascular risk profile of antirheumatic agents in patients with osteoarthritis and rheumatoid arthritis.

Nurmohamed MT, van Halm VP, Dijkmans BA.

Drugs. 2002;62(11):1599-609. Review.

PMID:
12109923

Supplemental Content

Support Center